Accent Microcell Ltd
Company Profile
Business description
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit), Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
Contact
Shyamal Cross Roads, Anandnagar Road
314, Shangrilla Arcade
Satellite
AhmedabadGJ380015
INDT: +91 7940042367
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
192
Stocks News & Analysis
stocks
Older cohorts the budget losers, not necessarily the ASX listed insurers
stocks
Investors overlooking ASX share’s potential
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,735.40 | 83.10 | -0.94% |
| CAC 40 | 7,970.37 | 17.82 | 0.22% |
| DAX 40 | 24,247.58 | 297.01 | 1.24% |
| Dow JONES (US) | 49,441.19 | 84.98 | -0.17% |
| FTSE 100 | 10,296.59 | 101.22 | 0.99% |
| HKSE | 25,675.18 | 287.55 | -1.11% |
| NASDAQ | 26,004.25 | 220.89 | -0.84% |
| Nikkei 225 | 60,815.95 | 593.34 | -0.97% |
| NZX 50 Index | 12,762.92 | 202.09 | -1.56% |
| S&P 500 | 7,375.44 | 33.06 | -0.45% |
| S&P/ASX 200 | 8,505.30 | 72.60 | -0.85% |
| SSE Composite Index | 4,131.53 | 3.86 | -0.09% |